← back to search

Thomas S. Hayday

Xenetic Biosciences (United Kingdom) · GB
Area of research
Infectious Diseases · Immunology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.
h-index
14
citations
2,238
works
20
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
The Lancet Oncology 2021cited by 611position: middledoi
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients
Cancer Cell 2021cited by 116position: middledoi
A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 1,028position: middledoi
Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate
Nature Communications 2020cited by 91position: middledoi
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 68position: middledoi
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis
Nature Medicine 2020cited by 15position: middledoi
Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23
The American Journal of Human Genetics 2017cited by 35position: middledoi
Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2
Molecular Therapy 2015cited by 45position: middledoi
Acquisition of MHC:Peptide Complexes by Dendritic Cells Contributes to the Generation of Antiviral CD8+ T Cell Immunity In Vivo
The Journal of Immunology 2012cited by 48position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Giovanna Lombardi · King's College London1 papers (2012–2012)Lesley A. Smyth · University of West London1 papers (2012–2012)— · 1 papers (2015–2015)Robert I. Lechler · The Honourable Society of Lincoln's Inn1 papers (2012–2012)Robert Deans · Case Western Reserve University1 papers (2015–2015)Bart Vaes · KU Leuven1 papers (2015–2015)— · 1 papers (2015–2015)Richard J. Ellis · King's College London1 papers (2012–2012)Linda S. Klavinskis · King's College London1 papers (2012–2012)Sofia Rosenzweig · National Human Genome Research Institute1 papers (2020–2020)Ivona Aksentijevich · National Institutes of Health1 papers (2020–2020)Helen J. Lachmann · Royal Free London NHS Foundation Trust1 papers (2020–2020)— · 1 papers (2015–2015)Harriet A. Purvis · King's College London1 papers (2020–2020)— · 1 papers (2015–2015)Claudia Kemper · National Institutes of Health1 papers (2020–2020)Nancy S. Wang · Cleveland Clinic Lerner College of Medicine1 papers (2015–2015)Shereen Sabbah · King's College London1 papers (2015–2015)Caroline Hull · Guy's Hospital1 papers (2015–2015)Klaus Okkenhaug · National Institute for Public Health and the Environment1 papers (2020–2020)